Learn More About ReNeuron
ReNeuron wins grant for retinal cell therapy development
Appointment of US-based Chief Medical Officer
Product Development Update
Positive pre-clinical data in nerve injury
Phase II stroke data presented at AHA conference
at 25-04-2018 5:37:04
15 minute delayed share price from London Stock Exchange provided by Euroland.
